Skip to main content
. 2020 Dec 18;10(4):290. doi: 10.3390/jpm10040290

Figure 5.

Figure 5

Effect of entrectinib and combination treatment on cell viability and toxicity. Impact of entrectinib treatment in combination with (A) trametinib, (C) abemaciclib, (E) everolimus on cell viability in triplicates in the indicated cell models measured by ATP-based survival assays upon 72 h drug exposure. Combination index (CI) based on the distinct drug combinations (B) trametinib, (D) abemaciclib, (F) everolimus were calculated as published [20]. CI values < 0.9 indicates synergistic, CI = 0.9–1.2 additive and CI > 1.2 antagonistic effects.